Skip to main content
OpenTrials

Clinical trial condition

Adnexal Diseases

Explore clinical trials studying Adnexal Diseases. Study availability and eligibility vary by location and protocol.

3,514 public trials 685 recruiting studies
Refine in advanced search Browse all conditions

Adnexal Diseases trial results

Completed

EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT01489371

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +22 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • University of New Mexico Cancer Center Albuquerque, New Mexico, United States
View Trial Details
Completed

Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

NCT01381861

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California, San Diego La Jolla, California, United States
  • University of Southern California Los Angeles, California, United States
  • Palm Beach Cancer Institute West Palm Beach, Florida, United States
View Trial Details
Completed

LIPT - Liraglutide in Polycystic Ovary Syndrome

NCT02073929

Conditions
Adnexal Diseases, Cardiovascular Disease, Cardiovascular Diseases, +12 more
Locations
  • Dept. of Medicine and Dept. of Gyn-Obs, Herlev Hospital Herlev, Denmark
  • Herlev Hospital, Dept of Gynecology Herlev, Denmark
  • Dept. of Medicine and Dept. of Obstetrics and Gynaecology, Herlev Hospital Herlev, Denmark
View Trial Details

Related conditions